Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings


Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III 'BELIEVE' Study in Adults with Transfusion-Dependent Beta-Thalassemia )--Celgene Corporation and Acceleron Pharma Inc. today announced results from a phase III, randomized, double-blind, mul... )--Harris Williams & Co., a preeminent middle market investment bank focused on the advisory needs of clients worldwide for more than 25 years, announces that it ad... )--Ajax Health , a privately held clinical-stage platform company focused on developing medical technologies, announced today the closing of an oversubscri... )--Cactus, Inc. announced today that it has commenced an underwritten public offering of 10,000,000 shares of its Class A common stock... )--Shionogi & Co., Ltd. has announced that effective... )--Ares Management, L.P. announced today that it will report earnings for the ... (more)



from Biotech News